quantisnow
FeedTopReportsPricing
⌘K
Live feed
12:42:14·848d
NEWSRelease
AstraZeneca PLC logo
Bristol-Myers Squibb Company logo
Fusion Pharmaceuticals Inc. logo
+3

Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned

AZN· AstraZeneca PLCBMY· Bristol-Myers Squibb CompanyFUSN· Fusion Pharmaceuticals Inc.LLY· Eli Lilly and CompanyPNT· POINT Biopharma Global Inc.RYZB· RayzeBio Inc.
Health Care
Original source

Companies

  • AZN
    AstraZeneca PLC
    Health Care
  • BMY
    Bristol-Myers Squibb Company
    Health Care
  • FUSN
    Fusion Pharmaceuticals Inc.
    Health Care
  • LLY
    Eli Lilly and Company
    Health Care
  • PNT
    POINT Biopharma Global Inc.
    Health Care
  • RYZB
    RayzeBio Inc.

Recent analyst ratings

  • Mar 17LLYUpdateHSBC Securities$850.00
  • Feb 25LLYUpdateRBC Capital Mkts$1,250
  • Feb 25BMYUpdateRBC Capital Mkts$60.00
  • Feb 20LLYUpdateBarclays$1,350
  • Feb 20BMYUpdateBarclays$75.00
  • Jan 27AZNUpdateCitigroup-

Related

  • PR4h
    Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
  • PR1d
    Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
  • PR1d
    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
  • SEC1d
    SEC Form 6-K filed by AstraZeneca PLC
  • INSIDER2d
    SEC Form 4 filed by Sulzberger Gabrielle
  • INSIDER2d
    SEC Form 4 filed by Luciano Juan R
  • INSIDER2d
    SEC Form 4 filed by Fyrwald J Erik
  • INSIDER2d
    SEC Form 4 filed by Alvarez Ralph
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022